Skip to main content

Advertisement

SpringerLink
Log in

Anti-glomerular basement membrane antibody disease in Japan: part of the nationwide rapidly progressive glomerulonephritis survey in Japan

  • Review Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Anti-glomerular basement membrane (anti-GBM) antibody disease is a rare, but well characterized cause of glomerulonephritis. It is defined by the presence of autoantibodies directed at specific antigenic targets within the glomerular basement membrane. This pattern of rapidly progressive glomerulonephritis and alveolar hemorrhage is often referred to as Goodpasture’s syndrome. The prognosis for patients with anti-GBM antibody disease is poor. In Japan, to improve the prognosis of patients with rapidly progressive glomerulonephritis (RPGN), we conducted a nationwide survey of patients with RPGN and investigated the initial symptoms, laboratory findings including renal biopsy findings, treatment methods, and outcomes. Among patients with RPGN, patients with anti-GBM antibody disease were rare: 6.6% (47/715). Alveolar hemorrhage (Goodpasture’s syndrome) was observed in 23.4% of patients with anti-GBM antibody disease. Most patients with anti-GBM antibody disease had renal failure at the time of diagnosis. The mean serum creatinine level of patients with renal-limited anti-GBM antibody disease was 7.07 ± 4.21 mg/dl and that of patients with Goodpasture’s syndrome was 7.99 ± 4.31 mg/dl. The mean level of crescent formation was 78.99 ± 23.54% in patients with anti-GBM antibody disease, and a cellular crescent form was observed in 63.2% of those patients. The prognosis for patients with anti-GBM antibody disease is poor; the renal survival rate at 6 months after onset was 20.9%, and the mortality at 6 months after onset was 23.3%. To improve the prognosis for anti-GBM antibody disease, it may be necessary to detect this disease in the early stages and to treat it without delay.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Goodpasture EW. The significance of certain pulmonary lesions in relation to the etiology of influenza. Am J Med Sci. 1919;158:863–70.

    Article  Google Scholar 

  2. Stanton MC, Tange JD. Goodpasture’s syndrome (pulmonary haemorrhage associated with glomerulonephritis). Aust N Zeal J Med. 1958;7:132–44.

    CAS  Google Scholar 

  3. Masugi M. Über die experimentelle glomerulonephritis durch das spezifische antinieren serum. Ein beiträg zur pathogenese der diffusen glomerulonephritis. Beitr Pathol Anat. 1934;92:429–66.

    Google Scholar 

  4. Ortega LG, Mellors RC. The role of localized antibodies in the pathogenesis of nephrotoxic nephritis in the rat. J Exp Med. 1956;104:151–70.

    Article  CAS  Google Scholar 

  5. Scheer RL, Grossman MA. Immune aspects of the glomerulonephritis associated with pulmonary hemorrhage. Ann Intern Med. 1964;60:1009–21.

    Article  Google Scholar 

  6. Lerner RA, Glassock RJ, Dixon FJ. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med. 1967;126:989–1004.

    Article  CAS  Google Scholar 

  7. Turner AN, Rees AJ. Antiglomerular basement membrane disease. In: Davison AM, Cameron JS, Grünfeld J-P, Kerr DNS, Ritz E, Winearls CG, editors. Oxford textbook of nephrology. 2nd ed. Oxford: Oxford University Press;1998. pp. 645–66.

    Google Scholar 

  8. Wilson CB, Dixon FJ. Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int. 1973;3:74–89.

    Article  CAS  Google Scholar 

  9. Couser WG. Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis. 1988;11:449–64.

    Article  CAS  Google Scholar 

  10. Andrassy K, Kuster S, Waldherr R, Ritz E. Rapidly progressive glomerulonephritis: Analysis of prevalence and clinical course. Nephron. 1991;59:206–12.

    Article  CAS  Google Scholar 

  11. Sakai H, Kurokawa K, Koyama A, et al. The management of rapidly progressive glomerulonephritis. Jpn J Nephrol. 2002;44:55–82 (in Japanese).

    Google Scholar 

  12. Churg J, Bernstein J, Glassock RJ. Classification of glomerular disease. In: Churg J, Bernstein J, Glassock RJ, editors. Renal disease. Classification and atlas of glomerular diseases, 2nd ed. New York, Tokyo: Igaku-Shoin;1995. pp. 1–13.

    Google Scholar 

  13. Angangco R, Thiru S, Esnault VL, Short AK, Lockwood CM, Oliveira DB. Does truly ‘idiopathic’ crescentic glomerulonephritis exist? Nephrol Dial Transplant. 1994;9:630–6.

    Article  CAS  Google Scholar 

  14. Jennette JC. Crescentic glomerulonephritis. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, editors. Heptinstall’s pathology of the kidney, 5th ed. Philadelphia, New York:Lippincott-Raven;1998. pp. 625–56.

    Google Scholar 

  15. Segelmark M, Butkowski R, Wieslander J. Antigen restriction and IgG subclasses among anti-GBM autoantibodies. Nephrol Dial Transplant. 1990;5:991–6.

    Article  CAS  Google Scholar 

  16. Merkel F, Pullig O, Marx M, Netzer KO, Weber M. Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: Report of 35 cases. Nephrol Dial Transplant. 1994;9:372–6.

    CAS  PubMed  Google Scholar 

  17. Jayne DR, Marshall PD, Jones SJ, Lockwood CM. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int. 1990;37:965–70.

    Article  CAS  Google Scholar 

  18. Bosch X, Mirapeix E, Font J, Borrellas X, Rodriguez R, López-Soto A, Ingelmo M, Revert L. Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol. 1991;36:107–13.

    CAS  PubMed  Google Scholar 

  19. Yang G, Tang Z, Chen Y, Zeng C, Chen H, Liu Z, Li L. Antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with anti-GBM crescentic glomerulonephritis. Clin Nephrol. 2005;63:423–8.

    Article  CAS  Google Scholar 

  20. Rutgers A, Slot M, van Paassen P, van Breda Vriesman P, Heeringa P, Tervaert JW. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis. 2005;46:253–62.

    Article  Google Scholar 

  21. Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD (2004) Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 66:1535–1540.

    Article  CAS  Google Scholar 

  22. Turner AN, Rees AJ Antiglomerular basement disease. In: Davison AM, Cameron JS, Grunfeld J-P, Ponticelli C, Ritz E, Winearls CG, van Ypersele C, editors. Oxford textbook of clinical nephrology, 3rd ed. Oxford: Oxford University Press;2005. pp. 579–600.

    Google Scholar 

  23. Benoit FL, Rulon DB, Theil GB, Doolan PD, Watten RH. Goodpasture’s syndrome: A clinicopathologic entity. Am J Med. 1963;58:424–44.

    Google Scholar 

  24. Proskey AJ, Weatherbee L, Easterling RE, Greene JA Jr, Weller JM. Goodpasture’s syndrome. A report of five cases and review of the literature. Am J Med. 1970;48:162–73.

    Article  CAS  Google Scholar 

  25. Beirne GJ, Wagnild JP, Zimmerman SW, Macken PD, Burkholder PM. Idiopathic crescentic glomerulonephritis. Medicine. 1977;56:349–81.

    Article  CAS  Google Scholar 

  26. Teague CA, Doak PB, Simpson IJ, Rainer SP, Herdson PB. Goodpasture’s syndrome: an analysis of 29 cases. Kidney Int. 1978;13:492–504.

    Article  CAS  Google Scholar 

  27. Briggs WA, Johnson JP, Teichman S, Yeager HC, Wilson CB. Antiglomerular basement membrane antibody-mediated glomerulonephritis and Goodpasture’s syndrome. Medicine. 1979;58:348–61.

    Article  CAS  Google Scholar 

  28. Peters DK, Rees AJ, Lockwood CM, Pusey CD. Treatment and prognosis in antibasement membrane antibody-mediated nephritis. Transplant Proc. 1982;14:513–21.

    CAS  PubMed  Google Scholar 

  29. Walker RG, Scheinkestel C, Becker GJ, Owen JE, Dowling JP, Kincaid-Smith P. Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture’s syndrome. Q J Med. 1985;54:75–89.

    CAS  PubMed  Google Scholar 

  30. Savage COS, Pusey CD, Bowman C, Rees AJ, Lockwood CM. Antiglomerular basement membrane antibody mediated disease in the British Isles 1980–4. Br Med J. 1986;292:301–4.

    Article  CAS  Google Scholar 

  31. Johnson JP, Moore JJ, Austin HA, Balow JE, Antonovych TT, Wilson CB. Therapy of anti-glomerular basement membrane antibody disease: Analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine. 1985;64:219–27.

    Article  CAS  Google Scholar 

  32. Herody M, Bobrie G, Gouarin C, Grunfeld JP, Noel LH. Anti-GBM disease: Predictive value of clinical, histological and serological data. Clin Nephrol. 1993;40:249–55.

    CAS  PubMed  Google Scholar 

  33. Daly C, Conlon PJ, Medwar W, Walshe JJ. Characteristics and outcome of anti-glomerular basement membrane disease: a single-center experience. Ren Fail. 1996;18:105–12.

    Article  CAS  Google Scholar 

  34. Li FK, Tse KC, Lam MF, Yip TP, Lui SL, Chan GS, et al. Incidence and outcome of antiglomerular basement membrane disease in Chinese. Nephrology. 2004;9:100–4.

    Article  Google Scholar 

  35. Cui Z, Zhao MH, Xin G, Wang HY. Characteristics and prognosis of Chinese patients with anti-glomerular basement membrane disease. Nephron Clin Pract. 2005;99:c49–55.

    Article  Google Scholar 

  36. Levy JB, Pusey CD. Still a role for plasma exchange in rapidly progressive glomerulonephritis? J Nephrol. 1997;10:7–13.

    CAS  PubMed  Google Scholar 

  37. Flores JC, Taube D, Savage CO, Cameron JS, Lockwood CM, Williams DG, Ogg CS. Clinical and immunological evolution of oligoanuric anti-GBM nephritis treated by haemodialysis. Lancet. 1986;1:5–8.

    Article  CAS  Google Scholar 

  38. Cohen LH, Wilson CB, Freeman RM. Goodpasture syndrome: Recovery after severe renal insufficiency. Arch Intern Med. 1976;136:835–7.

    Article  CAS  Google Scholar 

  39. Maxwell AP, Nelson WE, Hill CM. Reversal of renal failure in nephritis associated with antibody to glomerular basement membrane. Br Med J. 1988;297:333–4.

    Article  CAS  Google Scholar 

  40. de Torrente A, Popovtzer MM, Guggenheim SJ, Schrier RW. Serious pulmonary hemorrhage, glomerulonephritis, and massive steroid therapy. Ann Intern Med. 1975;83:218–9.

    Article  Google Scholar 

  41. Dahlberg PJ, Kurtz SB, Donadio JV, Holley KE, Velosa JA, Williams DE, Wilson CB. Recurrent Goodpasture’s syndrome. Mayo Clin Proc. 1978;53:533–7.

    CAS  PubMed  Google Scholar 

  42. Mehler PS, Brunvand MW, Hutt MP, Anderson RJ. Chronic recurrent Goodpasture’s syndrome. Am J Med. 1987;82:833–5.

    Article  CAS  Google Scholar 

  43. Hind CR, Bowman C, Winearls CG, Lockwood CM. Recurrence of circulating anti-glomerular basement membrane antibody three years after immunosuppressive treatment and plasma exchange. Clin Nephrol. 1984;21:244–6.

    CAS  PubMed  Google Scholar 

  44. Levy JB, Lachmann RH, Pusey CD. Recurrent Goodpasture’s disease. Am J Kidney Dis. 1996;27:573–8.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We acknowledge the people who participated in this Japanese nationwide survey and the members of the RPGN Clinical Guidelines Committee of Japan. The Japanese nationwide RPGN survey was supported by a grant-in-aid from the Research Fund for the Special Study Group on Progressive Glomerular Disease, the Ministry of Health, Labour and Welfare, Japan. The abstract was presented in Japanese at the 36th East-Japan annual meeting of the Japanese Society of Nephrology on 3 November 2006.

Author information

Authors and Affiliations

  1. Department of Nephrology, Tokyo Medical University Kasumigaura Hospital, 3-20-1 Chuo, Ami, Ibaraki, 300-0395, Japan

    Kouichi Hirayama & Masaki Kobayashi

  2. Department of Nephrology, Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Ten-nodai, Tsukuba, Ibaraki, 300-8575, Japan

    Kunihiro Yamagata

  3. Ibaraki Prefectural University for Health Sciences, 4669-2 Ohaza Ami, Ami, Ibaraki, 300-0394, Japan

    Akio Koyama

Authors
  1. Kouichi Hirayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kunihiro Yamagata
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masaki Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Akio Koyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kouichi Hirayama.

Additional information

Presented at the 36th Eastern Regional Meeting of the Japanese Society of Nephrology.

About this article

Cite this article

Hirayama, K., Yamagata, K., Kobayashi, M. et al. Anti-glomerular basement membrane antibody disease in Japan: part of the nationwide rapidly progressive glomerulonephritis survey in Japan. Clin Exp Nephrol 12, 339–347 (2008). https://doi.org/10.1007/s10157-008-0051-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-008-0051-8

Keywords

Search

Navigation